Dosing that fits into her schedule

An oral option in a compact blister pack

ORIAHNN Packaging.

Packaging shown is not actual size.

ONE capsule taken twice a day1:

Morning Icon.

One yellow and white capsule in the morning

combination of elagolix with E2/NETA

Clock Icon.

Should be taken at approximately the same time each day1

Evening Icon.

One blue and white capsule in the evening

elagolix alone

Calendar Icon.

Use of ORIAHNN should be limited to 24 months1

Silverware Icon.

ORIAHNN can be taken with or without food1

Silverware Icon

ORIAHNN can be taken with or without food1 

Missed dose1

If a dose is missed, instruct the patient to take the missed dose of ORIAHNN within 4 hours of the time that it was supposed to be taken and then the next dose at the usual time

  • If >4 hours have passed since the time ORIAHNN is usually taken, the dose should be skipped and the next dose should be taken at the usual time
  • Only 1 morning and 1 evening capsule should be taken per day

Treatment considerations1

  • Exclude pregnancy OR start within 7 days from the onset of menses
  • Advise women to use non-hormonal contraception during treatment and for 28 days after discontinuing ORIAHNN
  • Assessment of BMD by DXA is recommended at baseline and periodically thereafter

Patient counseling

Use this patient-friendly digital tool to discuss ORIAHNN efficacy, safety, dosing, and more with your patients

BMD=bone mineral density; DXA=dual-energy x-ray absorptiometry; E2/NETA=estradiol/norethindrone acetate.

*The ORIAHNN free trial provides a single 28-day trial supply of ORIAHNN at no cost to new patients residing in the United States with a valid prescription for an FDA-approved indication of ORIAHNN and who enroll in Oriahnn Complete. The trial is intended solely to allow new patients not currently taking ORIAHNN to determine with their healthcare provider whether ORIAHNN is right for them. There is no obligation to continue use of ORIAHNN after the trial has concluded and this program does not guarantee insurance coverage. Eligible patients are limited to one 28-day trial supply and may not re-enroll. The ORIAHNN trial supply will be dispensed only through an AbbVie-authorized pharmacy to the patient’s home address and may not be sold or further distributed. No claims for payment may be submitted to any third party insurance plan for product dispensed by program. AbbVie reserves the right to change or discontinue the trial at any time without notice. The trial is not health insurance and is not a discount, coupon, rebate or financial assistance program. Limitations may apply.